<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The aging kidney</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The aging kidney</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">The aging kidney</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew D Rule, MD, MSc</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard J Glassock, MD, MACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gary C Curhan, MD, ScD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert Q Lam, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 11, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H9530757"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The aging kidney is a topic of great interest in geriatric medicine and clinical nephrology. In 1999, glomerular filtration rate (GFR)-estimating equations started to replace serum creatinine for the evaluation of kidney function. Since that time, more and more older adults have been identified and labeled as having chronic kidney disease (CKD). Approximately one-half of adults over the age of 70 years have a measured or estimated GFR (eGFR) &lt;60 mL/min/1.73 m<sup>2</sup> [<a href="#rid1">1</a>], an advocated threshold to diagnose CKD [<a href="#rid2">2</a>]. Thus CKD, diagnosed by examination of eGFR, is largely a problem of older adults, and populations with higher prevalence of the aged will experience a higher burden of CKD [<a href="#rid3">3</a>].</p><p>This higher prevalence of diagnosed CKD is not simply due to increased recognition of diseases that tend to cluster in older adults, such as antineutrophil cytoplasmic antibody (ANCA)-positive small-vessel vasculitis, amyloidosis, diabetic nephropathy, nonamyloid monoclonal immunoglobulin deposition diseases, membranous nephropathy, and chronic tubulointerstitial disorders. Rather, much of the increased rate of CKD diagnoses in the older adult population results from the interpretation that normal structural and functional changes that occur in the kidney with aging are a manifestation of a "chronic disease of the kidneys" [<a href="#rid4">4</a>], an interpretation with which we disagree. Many have argued that this increased recognition of CKD is a positive development and leads to better care in older adult populations [<a href="#rid5">5,6</a>]. Others have argued that this is a harmful development that has led to unnecessary labeling of far too many older patients as "diseased" without any proven clinical benefit [<a href="#rid7">7-11</a>].</p><p>This review describes the structural and functional changes in the kidney with <strong>normal</strong> aging and the clinical significance of these changes. Issues related to estimation of GFR, the definition of CKD, and evaluation of patients with CKD are discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2359.html" rel="external">"Assessment of kidney function"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16406.html" rel="external">"Definition and staging of chronic kidney disease in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7188.html" rel="external">"Diagnostic approach to adult patients with subacute kidney injury in an outpatient setting"</a>.)</p><p></p><p class="headingAnchor" id="H9530763"><span class="h1">NORMAL AGING VERSUS CHRONIC DISEASE</span><span class="headingEndMark"> — </span>Aging is a natural and inevitable biological process that results in structural and functional changes in many organ systems. The kidney systematically loses function (eg, glomerular filtration rate [GFR]) and undergoes anatomical changes (senescence) with age. In addition to specific kidney diseases that are common in older adults, such as diabetic nephropathy, physiological senescence of the kidney occurs, even with healthy aging [<a href="#rid4">4</a>]. A similar process occurs in the lung, which systematically loses function (ie, forced expiratory volume in one second), even among "healthy" adults [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/6971.html" rel="external">"Selecting reference values for pulmonary function tests"</a>.)</p><p>It can sometimes be difficult to distinguish the structural and functional changes of a kidney affected by a specific preventable or treatable disease from those of a kidney undergoing the inevitable consequences of aging. However, even if the reduction in function is not preventable or treatable, senescent changes in the kidney are relevant and important to managing older patients. Specifically, loss of kidney function reserve with aging has the following clinical significance (see <a class="local">'Clinical significance of the aging kidney'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>More advanced disease if a new specific nephropathy, such as diabetic nephropathy or vasculitis, develops</p><p class="bulletIndent1"><span class="glyph">●</span>Increased susceptibility to acute kidney injury</p><p class="bulletIndent1"><span class="glyph">●</span>Toxic accumulation of medications cleared by the kidney</p><p class="bulletIndent1"><span class="glyph">●</span>The need for age-appropriate criteria in the selection of living kidney donors</p><p></p><p class="headingAnchor" id="H5974750"><span class="h2">Living kidney donors as a resource to examine normal aging</span><span class="headingEndMark"> — </span>Living kidney donors are a unique and important resource for understanding the structural and functional changes of normal aging. Kidney donors are systematically and meticulously evaluated to confirm "health" or at least "healthy for age" as currently understood. This provides the opportunity to characterize the physiological changes in the kidney with optimal aging. Kidney donors undergo kidney function testing, urinalysis, and contrast computed tomography (CT) angiograms as part of their evaluation. In addition, some transplant centers obtain implantation kidney biopsies (ie, "time zero" kidney biopsies) at the time of surgical donation. Autopsy studies of the general population (identified by sudden deaths) can also characterize structural changes in the kidney with aging, but they lack simultaneous kidney function and other clinical evaluations [<a href="#rid13">13</a>]. By contrast, general population studies of the aging kidney in living humans rely upon nonspecific biomarkers to evaluate the kidney since structural characteristics of the kidney are not typically available.</p><p>Many examples of studies from living kidney donors are presented in the ensuing discussions of structural and functional changes with aging. (See <a class="local">'Structural changes of the kidneys with aging'</a> below and <a class="local">'Functional changes of the kidneys with aging'</a> below.)</p><p class="headingAnchor" id="H5974756"><span class="h1">STRUCTURAL CHANGES OF THE KIDNEYS WITH AGING</span><span class="headingEndMark"> — </span>Various structural changes occur with aging, including microanatomic changes, such as nephrosclerosis and a decline in nephron number, and macroanatomic changes, such as decreased kidney cortical volume and the development of kidney cysts.</p><p class="headingAnchor" id="H9530769"><span class="h2">Microanatomical changes of the kidneys with aging</span><span class="headingEndMark"> — </span>The major microanatomical changes that occur with aging are nephrosclerosis and nephron hypertrophy.</p><p class="headingAnchor" id="H9530776"><span class="h3">Nephrosclerosis</span><span class="headingEndMark"> — </span>The primary structural finding of the aging kidney on light microscopy is nephrosclerosis, characterized by an increased detection of focal and global glomerulosclerosis, tubular atrophy, interstitial fibrosis, and fibrointimal hyperplasia (arteriosclerosis). In a study of kidney transplant donors, nephrosclerosis, defined as the combination of two or more of glomerulosclerosis (global not segmental), tubular atrophy, interstitial fibrosis, or arteriosclerosis, increased from 2.7 percent in kidneys from 18- to 29-year-olds to 73 percent in kidneys from 70- to 77-year-olds. The difference in global nephrosclerosis comparing two kidneys separated in age by eight years was roughly equivalent to the difference in nephrosclerosis comparing a kidney from a hypertensive donor with a similarly aged nonhypertensive donor [<a href="#rid14">14</a>].</p><p>Nephrosclerosis is likely due to an ischemic injury of the nephrons that is thought to result from arteriosclerosis and hyalinosis of small arteries. With ischemic injury, the glomerulus develops wrinkled capillary tufts, thickened basement membranes, and pericapsular fibrosis, eventually leading to collapse of the tuft and a diminutive, globally sclerosed glomerulus with collagen deposition filling Bowman's space [<a href="#rid15">15-18</a>]. Some of these obsolescent glomeruli may subsequently undergo complete absorption [<a href="#rid19">19,20</a>]. The tubule associated with the sclerotic glomerulus also atrophies, and the interstitium surrounding the atrophic tubule undergoes fibrosis [<a href="#rid14">14,21,22</a>]. Glomerulosclerosis, tubular atrophy, and interstitial fibrosis on biopsy of kidney donors correlate with the presence of arteriosclerosis [<a href="#rid14">14</a>].</p><p>The reasons why nephrosclerosis occurs with aging are not fully understood. Increased DNA methylation, a biomarker of biological aging, is evident on tissue biopsies from older kidneys. However, DNA methylation does not associate with the nephrosclerosis of aging [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H2585245809"><span class="h3">Glomerulosclerosis</span><span class="headingEndMark"> — </span>The focal and global glomerulosclerosis of aging has been described in a variety of populations, including living kidney donors [<a href="#rid14">14,18,20,22,24-26</a>]. There is reduction in podocyte density throughout life that may also cause glomerular tuft collapse and contribute to age-related glomerulosclerosis via a nonischemic pathway [<a href="#rid27">27</a>]. The upper reference limit (95<sup>th</sup> percentile) for the number of globally sclerotic glomeruli expected on biopsy according to age was determined in 1847 normotensive living kidney donors [<a href="#rid28">28</a>]. In a kidney biopsy showing 20 glomeruli, for example, up to 1 glomerulus would be expected to be globally sclerotic in a 25-year-old, but up to 6 would be expected to be globally sclerotic in a 75-year-old. Among patients with nephrotic syndrome who undergo kidney biopsy and those with other kidney diseases, the risk for progressive chronic kidney disease (CKD) is best identified using these age-specific reference limits for global glomerulosclerosis [<a href="#rid29">29,30</a>].</p><p>The global glomerulosclerosis associated with older age occurs almost entirely in the superficial cortex, whereas global glomerulosclerosis associated with lower glomerular filtration rate (GFR), proteinuria, hypertension, interstitial fibrosis, and diabetes mellitus occurs more diffusely or in the deeper cortex [<a href="#rid31">31</a>]. Superficial glomeruli are the most distal glomeruli perfused by the renal artery, and age-related glomerulosclerosis is consistent with an ischemic process from arteriosclerosis [<a href="#rid31">31</a>].</p><p>By contrast, a lesion of focal segmental glomerulosclerosis (FSGS) is <strong>not</strong> observed as a component of normal aging in human kidneys and, when present, should be considered pathological. (See  <a class="medical medical_review" href="/d/html/3049.html" rel="external">"Focal segmental glomerulosclerosis: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H555989155"><span class="h3">Nephron number in aging kidneys</span><span class="headingEndMark"> — </span>The number of functional nephrons with which a person is born (ie, nephron endowment) varies between 700,000 and 1.8 million per kidney, and the number progressively declines with aging due to nephrosclerosis [<a href="#rid32">32-34</a>]. The total number of nephrons (nonsclerosed glomeruli) in living kidney donors decreases from 990,000 per kidney for ages 18 to 29 years to 520,000 per kidney for ages 70 to 75 years [<a href="#rid35">35</a>] or approximately 50 nonsclerosed glomeruli lost per day. This loss of nonsclerosed glomeruli with aging is not simply explained by an increasing fraction of globally sclerosed glomeruli. As glomeruli sclerose with aging, there appears to be eventual absorption of these sclerosed glomeruli, and the total number of glomeruli (sclerosed and nonsclerosed) declines with age [<a href="#rid19">19,20,35</a>].</p><p>There is progressive atrophy of the corresponding tubule attached to the sclerosed glomeruli. The atrophic tubules that accumulate with age progressively atrophy and create a scattered pattern with multiple small foci of interstitial fibrosis and tubular atrophy [<a href="#rid36">36</a>]. Over time these small "scars" may gradually be absorbed. This process of atrophy and absorption of age-related nephrosclerosis also explains the small amount of interstitial fibrosis and tubular atrophy evident in the cortex with healthy aging despite the substantial nephron loss since birth [<a href="#rid14">14</a>].  </p><p>Low nephron endowment associated with low birth weight may accelerate the age-related decline in functional nephrons in adulthood [<a href="#rid37">37-40</a>]. Thus, the evaluation of nephron loss with aging must take into account the number of nephrons present at birth.  </p><p class="headingAnchor" id="H9530782"><span class="h3">Nephron hypertrophy</span><span class="headingEndMark"> — </span>Nephron size (both glomerulus and tubule) increases in a variety of metabolic risk states, including obesity and diabetes, due to cellular hypertrophy and hyperplasia [<a href="#rid41">41-43</a>]. In parallel with age-related glomerulosclerosis [<a href="#rid44">44,45</a>], hypertrophy of the remaining functional nephrons also occurs [<a href="#rid46">46,47</a>]. This appears to be due primarily to hypertrophy of renal tubules rather than the glomeruli [<a href="#rid48">48</a>]. Nephron (tubular) hypertrophy leads to a decrease in nephron density (glomerular number per mm<sup>2</sup> of a histologic section) due to spreading of the space between glomeruli. Glomerular enlargement is seen with aging in the presence of age-related comorbidities [<a href="#rid27">27,49</a>]. However, healthy aging in older kidney donors is not associated with an increase in glomerular volume [<a href="#rid47">47,48</a>]. Consistent with this finding, neither glomerular filtration capacity [<a href="#rid33">33</a>] nor single-nephron GFR [<a href="#rid50">50</a>] increases with healthy aging [<a href="#rid48">48</a>]. Any glomerular hypertrophy observed in older subjects is more likely due to comorbid factors, such as obesity, diabetes, or loss of nephrons from disease. When the supply of nephrons is inadequate (such as from low nephron endowment at birth), even for the reduced metabolic needs of older individuals, this can lead to nephron overload and progressive CKD [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H9530788"><span class="h3">Other microanatomical changes</span><span class="headingEndMark"> — </span>Microdissection of nephrons from autopsied kidneys shows a strong association between aging and frequency of tubular diverticula [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H9530794"><span class="h2">Macroanatomical changes of the kidneys with aging</span><span class="headingEndMark"> — </span>The major macroanatomical changes that occur with aging include a reduction in cortical volume and the appearance of kidney cysts and tumors.</p><p class="headingAnchor" id="H9530802"><span class="h3">Kidney volume</span><span class="headingEndMark"> — </span>Radiographic imaging studies have elucidated the age-related changes in the kidney volume. A decline in total kidney volume with aging was noted in clinical populations using ultrasound or computerized tomography (CT) [<a href="#rid52">52-56</a>]. In one study, the rate of age-related decline was significantly faster in patients with underlying atherosclerosis (estimated from carotid intima-media thickness) [<a href="#rid55">55</a>]. In the general population, total kidney volume by magnetic resonance imaging (MRI) declined with older age but not after adjusting for age differences in eGFR and comorbidities [<a href="#rid57">57</a>].</p><p>Some studies in living kidney donors failed to detect a decline in kidney volume with age, but these studies had small sample sizes and included few older donors [<a href="#rid45">45,58,59</a>].</p><p>In a large study of 1344 potential kidney donors, kidney parenchymal volume was stable before age 50 years but declined after age 50 years [<a href="#rid60">60</a>]. This study also separately measured the kidney cortical and medullary volumes. Cortical volume declined throughout the adult age spectrum in both males and females, but with an accelerated rate of decline after age 50 years [<a href="#rid60">60</a>]. By contrast, medullary volume increased with age in both males and females until age 50 years, after which it declined in females and remained static in males [<a href="#rid60">60</a>]. Renal sinus fat increases with age; this could have masked some of the decline in kidney parenchymal volume with aging in studies that included sinus fat in kidney volume or weight measurements [<a href="#rid35">35,52,53</a>].</p><p class="headingAnchor" id="H9530808"><span class="h4">Microanatomical connections to kidney volume</span><span class="headingEndMark"> — </span>The age-related decline in kidney cortical volume is largely due to underlying nephrosclerosis (senescent global glomerulosclerosis and atrophy of tubules are lesions that decrease the volume occupied by nephrons) [<a href="#rid48">48</a>]. Some of the preservation of kidney parenchymal volume with aging can be explained by compensatory hypertrophy of the remaining functional tubules [<a href="#rid20">20,44,46,48,49,61</a>]. Increased medullary volume with aging can be explained by hypertrophy of tubules attached to juxtamedullary glomeruli in compensation for atrophy (glomerulosclerosis and nephrosclerosis) of the more superficial nephrons in the cortex [<a href="#rid62">62</a>]. There appears to be a more accelerated loss of total kidney parenchymal volume after middle age (approximately 50 years) [<a href="#rid3">3,60,63-65</a>]. This may be the point at which hypertrophy of functional nephrons no longer compensates for the volume lost from sclerosed and atrophied nephrons [<a href="#rid46">46</a>]. This compensatory hypertrophy of healthy tubules for age-related nephrosclerosis makes total kidney volume and kidney cortical volume poor markers of age-related nephron loss [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H9530814"><span class="h3">Kidney cysts and tumors</span><span class="headingEndMark"> — </span>Kidney parenchymal cysts become more common, more numerous, and larger with aging [<a href="#rid66">66,67</a>]. Age-related diverticula in renal tubules are the precursor lesion to these kidney cysts [<a href="#rid68">68</a>]. Because of this age-related increase in kidney cysts, the diagnosis of autosomal dominant polycystic kidney disease (ADPKD) with kidney ultrasound imaging requires age-specific criteria (Ravine criteria) [<a href="#rid69">69</a>]. CT scans have higher resolution and can detect smaller cysts not seen by ultrasound. The figure shows the upper limit of normal (97.5<sup>th</sup> percentile) for the number of cortical and medullary cysts detected by CT according to age and sex  (<a class="graphic graphic_table graphicRef91443" href="/d/graphic/91443.html" rel="external">table 1</a>) [<a href="#rid67">67</a>]. Although kidney cysts that are not associated with malignancy or a polycystic disorder are often called "benign" or "simple," they frequently reflect chronic underlying parenchymal injury of the aging kidney and are associated with increased urine albumin excretion. In addition to parenchymal simple kidney cysts, other kidney cysts are also more common with aging, including parapelvic kidney cysts (due to lymphatic dilation near the renal sinus), hyperdense cysts, angiomyolipomas, and malignant cysts or tumors [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H9530820"><span class="h3">Other macroanatomical changes</span><span class="headingEndMark"> — </span>Atherosclerosis of renal arteries (with or without significant stenosis) is more prevalent in older individuals, ranging from 0.4 percent in 18- to 29-year-olds to 25 percent in 60- to 75-year-olds [<a href="#rid70">70</a>]. Fibromuscular dysplasia (FMD) also becomes more prevalent with aging, though it is much more common in females [<a href="#rid70">70</a>]. Compared with the smooth surface of younger kidneys, older kidneys have a more irregular, rough surface consistent with the effects of nephrosclerosis [<a href="#rid48">48</a>]. In addition, parenchymal calcifications and cortical scars (a focal atrophic region of cortex) are more common with aging [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H9530832"><span class="h1">FUNCTIONAL CHANGES OF THE KIDNEYS WITH AGING</span><span class="headingEndMark"> — </span>Glomerular filtration rate (GFR) is the primary tool for assessing age-related functional changes in the kidney and is typically the only tool for examining age-related changes since kidney biopsy and kidney imaging are not typically justified in routine patient care.</p><p class="headingAnchor" id="H9530838"><span class="h2">GFR declines with normal aging</span><span class="headingEndMark"> — </span>Rates of glomerular filtration rate (GFR) decline with aging follow a fairly normal (Gaussian) distribution, suggesting that it is primarily driven by a physiological process [<a href="#rid71">71</a>]. Not only does the lower reference limit for GFR decrease with age, but the upper reference limit also decreases with age  (<a class="graphic graphic_table graphicRef91445" href="/d/graphic/91445.html" rel="external">table 2</a>) [<a href="#rid72">72-76</a>]. If GFR is preserved in some persons with healthy aging, then the upper limit of normal (95<sup>th</sup> or 97.5<sup>th</sup> percentile) among healthy adults should be stable or only slightly decrease with aging. Some studies with GFR measurements among healthy adults across the age spectrum have refuted this hypothesis. As an example, one study found that the 95<sup>th</sup> percentile for GFR decreased by 38 mL/min/1.73 m<sup>2</sup> from age 18 to 70 years [<a href="#rid75">75</a>]. Another study found the 97.5<sup>th</sup> percentile for GFR decreased by 30 mL/min/1.73 m<sup>2</sup> from age 50 to 90 years, and the 2.5<sup>th</sup> percentile for healthy 50 year olds was similar to the 97<sup>th</sup> percentile for healthy 95 year olds [<a href="#rid76">76</a>]. Furthermore, population level variability in GFR did not increase with age as would be expected if a subset of older healthy persons had unrecognized kidney disease that contributed to their GFR decline [<a href="#rid76">76</a>]. Because of this universal or near-universal decline in GFR with aging, healthy persons over the age of 70 years are misidentified as having "chronic kidney disease (CKD)" based on a GFR &lt;60 mL/min/1.73 m<sup>2</sup> [<a href="#rid76">76</a>].</p><p>A longitudinal study of 254 males followed for 23 years found that the average GFR (estimated serially by urinary creatinine clearance) declined by 7.5 mL/min per decade of life [<a href="#rid71">71</a>]. Some of these individuals had diabetes or obesity, which could have impacted the results, and in fact, one-third of the cohort had an increase in their creatinine clearance over time, which likely reflected both hyperfiltration (seen with obesity, early diabetes, and subclinical cardiovascular disease [<a href="#rid77">77</a>]) and imprecision with urinary creatinine clearance measurements. (See  <a class="medical medical_review" href="/d/html/2378.html" rel="external">"Calculation of the creatinine clearance"</a> and  <a class="medical medical_review" href="/d/html/3064.html" rel="external">"Mechanisms of glomerular hyperfiltration in diabetes mellitus"</a>.)</p><p>Some investigators have attributed this GFR decline with normal aging to a high-sodium diet or some other pervasive influences of a "modern" or "Western" lifestyle. However, GFR decline with normal aging is also observed in populations unaffected by Western lifestyle factors. In an isolated population of Kuna Indians in Panama, for example, GFR (measured by inulin clearance) declined by 9.5 mL/min per decade of life, despite not having a Western lifestyle and not having an age-related increase in blood pressure that is typical of a Western lifestyle [<a href="#rid78">78-80</a>]. Thus, the decline in GFR with aging can be disassociated from the effects of increasing blood pressure.</p><p class="headingAnchor" id="H304438223"><span class="h3">Trajectory of decline in GFR in advanced age</span><span class="headingEndMark"> — </span>Data on the evolution of GFR in advanced age (over 70 to 75 years) are limited and largely cross-sectional. Individuals of advanced age often have associated comorbidity that further compounds the evaluation of physiologic versus disease-related changes. A comprehensive evaluation of the evolution of eGFR among older adults (mean age 80 years, range 70 to 99 years) was reported from the Berlin Initiative Study [<a href="#rid81">81</a>]. This longitudinal study included community-living subjects over 70 years of age, 91 percent of whom had at least one comorbidity. Diabetes was present in 26 percent, hypertension in 79 percent, heart failure in 29 percent, cancer in 23 percent, and approximately 26 percent had increased urinary albumin excretion; thus, this is not a study of "healthy" aging.  </p><p>Nevertheless, there was an annual decline in eGFR of -1.67 to -0.99 mL/min/1.73 m<sup>2</sup> for males and -1.52 to -0.97 mL/min/1.73 m<sup>2</sup> for females. These rates of decline are higher than those seen in adults less than 70 years of age. Of interest, there appeared to be a slowing of the rate of decline with aging in adults over 85 years old. It is possible that at late age an increase in single nephron GFR is a factor in this phenomenon. This study adds to our knowledge concerning the trajectory of eGFR in community-living (but largely unhealthy) older adults. However, it is not known whether this late aging attenuation of eGFR decline is due to GFR or non-GFR determinants, due to the lack of measured GFR in the study.   </p><p class="headingAnchor" id="H9530851"><span class="h3">Mechanistic basis for GFR decline with aging</span><span class="headingEndMark"> — </span>With age-related loss of nephrons, it is reasonable to ask whether the remaining glomeruli compensate to maintain glomerular filtration rate (GFR) [<a href="#rid82">82</a>]. Single-nephron GFR reflects the average function of remaining nephrons and does not increase but remains stable at 80 nL/min despite the substantial loss of nephrons with healthy aging [<a href="#rid50">50</a>]. This finding is further supported by the stable glomerular volume [<a href="#rid48">48</a>] and glomerular filtration capacity [<a href="#rid33">33</a>] with healthy aging. Single-nephron GFR does increase with factors that reflect increased metabolic demand such as very tall height or obesity [<a href="#rid50">50</a>], but the lack of a compensatory increase in single-nephron GFR for the age-related loss of nephrons suggests a declining metabolic demand for GFR with aging. Indeed, the GFR decline with aging has been linked to both lower urea generation and the lower metabolic rate with aging [<a href="#rid83">83,84</a>].</p><p>Nephrosclerosis is associated with an increase in single-nephron GFR but only when nephrosclerosis exceeds that expected for age [<a href="#rid50">50</a>]. Consistent with nephron loss but a stable single-nephron GFR with aging, cortical atrophy [<a href="#rid60">60</a>] and nephrosclerosis [<a href="#rid48">48</a>] with aging appear to follow the same biological pathway as the GFR decline with aging.</p><p class="headingAnchor" id="H9530864"><span class="h2">High proportion of older adults with reduced GFR</span><span class="headingEndMark"> — </span>The Kidney Disease Improving Global Outcomes (KDIGO) 2012 guidelines define and stage CKD by levels of glomerular filtration rate (GFR) and albuminuria  (<a class="graphic graphic_table graphicRef70597" href="/d/graphic/70597.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/16406.html" rel="external">"Definition and staging of chronic kidney disease in adults"</a>.)</p><p>Since nearly all healthy young adults have a GFR ≥90 mL/min/1.73 m<sup>2</sup>, this GFR range has been defined as "optimal" or "normal." A GFR of 60 to 89 mL/min/1.73 m<sup>2</sup> has been defined as "mildly decreased relative to young adult levels." Regardless of age, any GFR ≥60 mL/min/1.73 m<sup>2</sup> is not considered to be CKD unless some other criteria of "kidney damage" are met (eg, albuminuria) [<a href="#rid3">3</a>]. A study of 610 community-dwelling adults older than 70 years found that half had "CKD" as determined by a measured GFR &lt;60 mL/min/1.73 m<sup>2</sup> [<a href="#rid85">85</a>]. Often, a specific disease process for a GFR reduction to &lt;60 mL/min/1.73 m<sup>2</sup> in older adults cannot be identified (other than normal aging). One study found the lower reference limit for measured GFR to be 49 mL/min/1.73 m<sup>2</sup> at the age of 75 years among healthy potential kidney donors [<a href="#rid86">86</a>].</p><p class="headingAnchor" id="H9530870"><span class="h3">Estimated glomerular filtration rate (eGFR)</span><span class="headingEndMark"> — </span>Direct measurement of GFR is not available in most clinical settings. Instead, GFR is usually estimated from serum creatinine (eGFR<sub>creatinine</sub>) using the 2009 or 2021 Chronic Kidney Disease Epidemiology (CKD-EPI) equation [<a href="#rid87">87</a>]. As with measured GFR, approximately one-half of adults over the age of 70 years have CKD as determined by an eGFR<sub>creatinine</sub> &lt;60 mL/min/1.73 m<sup>2</sup> [<a href="#rid1">1</a>]. Creatinine-based GFR-estimating equations include an age variable to model the decline in creatinine generation (due to decreased muscle mass) with normal aging [<a href="#rid88">88</a>]. This age variable unmasks the age-related decline in GFR that is not detected by serum creatinine alone. Interestingly, the age-related decline in GFR is approximately canceled out by the age-related decline in muscle mass, such that serum creatinine remains stable with healthy aging [<a href="#rid89">89</a>], until late in life (over 70 years) when a small increase may occur [<a href="#rid90">90</a>]. The only way a patient can maintain a stable eGFR<sub>creatinine</sub> with aging is to have a progressive decrease in his or her serum creatinine level. However, a declining serum creatinine level can represent loss of muscle mass from a disease process (or treatments that lead to muscle wasting, such as glucocorticoids). A patient with a stable serum creatinine level who "ages into CKD" based upon eGFR<sub>creatinine</sub> &lt;60 mL/min/1.73 m<sup>2</sup> could have experienced nothing more than the expected age-related decline in GFR. Ideally, patients would lose neither GFR nor muscle mass with aging, and serum creatinine levels would still remain stable with aging [<a href="#rid91">91</a>].</p><p class="headingAnchor" id="H4642987"><span class="h3">When and how to confirm CKD in older adults</span><span class="headingEndMark"> — </span>Uncertainty regarding a reduction in GFR when using eGFR<sub>creatinine</sub> may exist when other evidence of chronic kidney disease (CKD) such as albuminuria is lacking, or when the muscle mass is more than average for the patient's age. When such uncertainty exists regarding the accuracy of eGFR<sub>creatinine</sub>, a urinary creatinine clearance or direct GFR measurement can further assess the kidney function of older adult patients. This may be particularly important when an accurate GFR assessment is needed for a patient who wants to donate a kidney. (See <a class="local">'Living kidney donor evaluation'</a> below.)</p><p>Older patients in good health and with higher-than-average muscle mass may meet the definition of CKD by eGFR<sub>creatinine</sub> &lt;60 mL/min/1.73 m<sup>2</sup> but may actually have a GFR ≥60 mL/min/1.73 m<sup>2</sup> using a confirmatory test. This can be reassuring to some older patients who are concerned about being diagnosed with CKD. However, if an older patient's urinary creatinine clearance or direct GFR measurement is still modestly reduced (eg, 45 to 59 mL/min/1.73 m<sup>2</sup>), it is still possible that this could be nothing more than a reduced GFR from normal aging. (See <a class="local">'What to do with isolated mild reductions in eGFR in older adults'</a> below.)</p><p>When confirmation of CKD is desired, the KDIGO guidelines suggest using GFR-estimating equations that are based upon cystatin C (eGFR<sub>cystatin C</sub>) or upon both creatinine and cystatin C (eGFR<sub>creatinine-cystatin C</sub>) [<a href="#rid92">92</a>]. Specifically, they suggest these calculations be made in patients with an eGFR<sub>creatinine </sub>of 45 to 59 mL/min/1.73 m<sup>2</sup> and no other markers of kidney damage [<a href="#rid3">3</a>]. There is improved discrimination of outcomes (end-stage kidney disease [ESKD] and mortality) with eGFR<sub>cystatin C</sub> or eGFR<sub>creatinine-cystatin C</sub> compared with eGFR<sub>creatinine</sub> [<a href="#rid3">3</a>]. However, the optimal GFR-estimating equation for predicting such outcomes does not necessarily reflect the true association between GFR and outcomes [<a href="#rid93">93</a>]. Unlike an elevated serum creatinine, elevated cystatin C occurs with other chronic diseases besides CKD. Cystatin C is a protease inhibitor that plays a role in atherosclerosis, obesity, and inflammation [<a href="#rid94">94-96</a>], and serum cystatin C associates with both CKD risk factors and the development of ESKD, independent of the patient's underlying GFR  (<a class="graphic graphic_figure graphicRef91446" href="/d/graphic/91446.html" rel="external">figure 1</a>) [<a href="#rid97">97-100</a>]. Thus, although patients with elevated serum cystatin C have a higher risk for ESKD, cardiovascular disease, and mortality, this risk may be mediated by factors other than kidney function (ie, GFR). As a result, we do not recommend use of eGFR<sub>cystatin C</sub> or eGFR<sub>creatinine-cystatin C</sub> to confirm a diagnosis of CKD in older patients with eGFR<sub>creatinine </sub>of 45 to 59 mL/min/1.73 m<sup>2</sup>.</p><p class="headingAnchor" id="H9530909"><span class="h3">Mortality and kidney failure risk with CKD from aging</span><span class="headingEndMark"> — </span>It is not clearly evident that the relationships between eGFR and death or ESKD support the use of a common threshold for chronic kidney disease (CKD) in all age groups. A meta-analysis by the CKD Prognosis Consortium studied 46 cohorts with 2,051,244 patients and found that a low eGFR<sub>creatinine</sub> was associated with mortality and ESKD in all age groups [<a href="#rid101">101</a>]. However, several features of this meta-analysis argue that a separate GFR threshold is needed for older adults:</p><p class="bulletIndent1"><span class="glyph">●</span>Among individuals without albuminuria, an isolated mild reduction in eGFR<sub>creatinine</sub> of 45 to 59 mL/min/1.73 m<sup>2</sup> (compared with 75 to 89 mL/min/1.73 m<sup>2</sup>) was associated with a 20 percent higher relative mortality in those 75 years and older, but a 179 percent higher relative mortality in those aged 18 to 54 years. Other studies have not found an increased risk of mortality in older adults with eGFR 45 to 59 mL/min/1.73 m<sup>2</sup> in the absence of albuminuria [<a href="#rid102">102,103</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The lowest risk for mortality in adults aged 18 to 54 years was with an eGFR<sub>creatinine</sub> ≥105 mL/min/1.73 m<sup>2</sup>. However, in adults aged 75 years and older, those with an eGFR<sub>creatinine</sub> in this range had a 60 percent higher relative mortality. If the separation between "normal" and "disease" is based upon risk, as suggested by KDIGO, then age-specific ranges are justified  (<a class="graphic graphic_figure graphicRef91447" href="/d/graphic/91447.html" rel="external">figure 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the KDIGO guidelines, an eGFR<sub>creatinine</sub> ≥90 mL/min/1.73 m<sup>2</sup> is used to define "optimal" or "normal" [<a href="#rid3">3</a>]. However, the meta-analysis performed by the CKD Prognosis Consortium to evaluate risks associated with isolated mild reductions in eGFR did not use this "normal" range as the reference group, thereby limiting the use of these data.</p><p></p><p>This meta-analysis was also not limited to representative samples of the general population as many high-risk cohorts were included [<a href="#rid101">101</a>]. Furthermore, serum creatinine levels were not consistently standardized, and the eGFR categories were based upon a single serum creatinine level rather than serum creatinine levels over at least three months to establish chronicity [<a href="#rid104">104</a>]. These limitations were addressed in two subsequent reports:</p><p class="bulletIndent1"><span class="glyph">●</span>A nationwide study in Iceland studied 218,437 adults and used the full KDIGO definition of CKD that required at least two outpatient determinations of eGFR<sub>creatinine</sub> obtained three months apart with standardized serum creatinine levels [<a href="#rid104">104</a>]. By these criteria, younger adults (ages 18 to 45 years) with an eGFR<sub>creatinine</sub> of 60 to 75 mL/min/1.73 m<sup>2</sup> and no proteinuria or specific kidney disease had an increased risk of mortality (standardized mortality ratio 3.0, 95% CI 1.1-5.9) despite not meeting criteria for CKD by an eGFR<sub>creatinine</sub> &lt;60 mL/min/1.73 m<sup>2</sup>. Alternatively, older adults (age &gt;65 years) with an eGFR<sub>creatinine</sub> of 45 to 59 mL/min/1.73 m<sup>2</sup> and no proteinuria or specific kidney disease did not have an increased risk of mortality (standardized mortality ratio 1.01, 95% CI 0.97-1.05) despite meeting criteria for CKD by an eGFR<sub>creatinine</sub> &lt;60 mL/min/1.73 m<sup>2</sup>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A population-based study of 127,132 adults in Alberta, Canada required sustained reductions in eGFR<sub>creatinine</sub> for at least three months to define CKD [<a href="#rid105">105</a>]. Among older persons (age &gt;65 years) with normal or mild albuminuria, the five-year risk of kidney failure with an eGFR<sub>creatinine</sub> of 45 to 59 mL/min/1.73 m<sup>2</sup> was very low (&lt;0.12 percent). The five-year risk of mortality with eGFR<sub>creatinine</sub> of 45 to 59 mL/min/1.73 m<sup>2</sup> was also consistent in magnitude with that of persons with an eGFR<sub>creatinine</sub> of 60 to 89 mL/min/1.73 m<sup>2</sup>. There was no significantly increased risk of mortality with eGFR<sub>creatinine</sub> of 45 to 59 mL/min/1.73 m<sup>2</sup> for ages 75 to 79 years (mortality hazard ratio [HR] 1.0, 95% CI 1.0-1.1) or for ages 80 years and older (mortality HR 0.9, 95% CI 0.8-0.9).</p><p></p><p class="headingAnchor" id="H8707703"><span class="h2">Other functional changes</span><span class="headingEndMark"> — </span>The kidneys of older patients demonstrate impaired kidney conservation of sodium in response to an acute reduction of sodium intake, as well as impaired ability to rapidly excrete a large sodium load. Animal studies show a decreased abundance of sodium chloride transporters and epithelial sodium channels with aging [<a href="#rid106">106</a>]. There is also loss of both the maximum urine concentrating ability (from approximately 1200 to 800 mosm/L) and the maximum urine diluting capacity (from approximately 50 to 100 mosm/L) [<a href="#rid107">107-110</a>]. The expression of aquaporins is reduced in the medulla with aging in animal models [<a href="#rid111">111</a>]. The reduced diluting capacity of the kidney increases the risk of hyponatremia in older patients, particularly those with a low-protein "tea and toast" diet that is consumed by some older adult patients. Changes in the diluting capacity also contributes to thiazide-associated hyponatremia, which is more common in older adults [<a href="#rid112">112</a>]. There is also a tendency toward hyperkalemia in older adults from hyporeninemic hypoaldosteronism [<a href="#rid113">113</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2374.html" rel="external">"Causes of hypotonic hyponatremia in adults", section on 'Low dietary solute intake'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2374.html" rel="external">"Causes of hypotonic hyponatremia in adults", section on 'Diuretic-induced hyponatremia'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)", section on 'Hyporeninemic hypoaldosteronism'</a>.)</p><p></p><p class="headingAnchor" id="H9530922"><span class="h1">CLINICAL SIGNIFICANCE OF THE AGING KIDNEY</span><span class="headingEndMark"> — </span>There are several important issues in the management of patients with age-related changes in kidney structure and function. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>There are no proven therapies to halt or reverse age-related declines in glomerular filtration rate (GFR). Any therapy aimed at raising the GFR by causing the remaining functional nephrons to filter more may actually be harmful rather than beneficial to the kidney, by inducing pathologic hyperfiltration per nephron. Hypertrophy and hyperfiltration of functional glomeruli in animals, for example, can lead to further glomerulosclerosis, probably mediated by podocyte stress or injury. (See  <a class="medical medical_review" href="/d/html/7181.html" rel="external">"Secondary factors and progression of chronic kidney disease", section on 'Intraglomerular hypertension and glomerular hypertrophy'</a>.)</p><p></p><p class="bulletIndent1">This is a key difference distinguishing age-related "chronic kidney disease (CKD)" from other age-related chronic disease such as hypertension or hyperlipidemia. Age-related hypertension and hyperlipidemia can be reversed, and reducing the blood pressure and cholesterol has clinical benefit in older adult patients. By contrast, generic therapies for CKD (such as angiotensin inhibitors and protein-restricted diets) do not reverse age-related GFR decline, and it is not clear that these therapies are of any benefit to an older adult with only age-related "CKD." A simulation study suggests that angiotensin inhibitors will have marginal benefit at most for age-related "CKD" [<a href="#rid114">114</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with age-related reductions in GFR may require medication dose adjustments, for water-soluble drugs cleared mainly by GFR. Lipid-soluble drugs and those metabolized to nontoxic end products do not need dose adjustment in the presence of low GFR. (See <a class="local">'Medication dosing'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The loss of functioning nephrons and resultant lower GFR associated with normal aging put older adults at higher risk for acute kidney injury. (See <a class="local">'Acute kidney injury'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A reduction in estimated GFR (eGFR) with normal aging (sometimes to the range of 45 to 59 mL/min/1.73 m<sup>2</sup> does <strong>not</strong> substantially improve the assessment of cardiovascular risk over conventional predictors and does <strong>not</strong> indicate a high risk of end-stage kidney disease (ESKD) at least when abnormal albuminuria is not present. (See <a class="local">'Cardiovascular morbidity and mortality risk'</a> below and <a class="local">'End-stage kidney disease'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Age-related declines in GFR do <strong>not</strong> typically prevent older adults from becoming living kidney donors. (See <a class="local">'Living kidney donor evaluation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Overall, the typical age-related declines in GFR (between 45 and 59 mL/min/1.73 m<sup>2</sup>) have little, if any, effect on life expectancy, and this point is important in discussions with older adult patients. (See <a class="local">'Counseling patients with CKD due to normal age-related GFR declines'</a> below.)</p><p></p><p class="headingAnchor" id="H3423094"><span class="h2">What to do with isolated mild reductions in eGFR in older adults</span><span class="headingEndMark"> — </span>There is controversy about whether or not to diagnose older adults with CKD based upon an eGFR<sub>creatinine</sub> of 45 to 59 mL/min/1.73 m<sup>2</sup> in the absence other evidence of CKD (such as albuminuria). An eGFR of 45 to 59 mL/min/1.73 m<sup>2</sup> has a modest though statistically significant association with adverse events such as death and ESKD in older adults, leading many experts and the Kidney Disease Improving Global Outcomes (KDIGO) group to endorse an eGFR &lt;60 mL/min/1.73 m<sup>2</sup> for diagnosing CKD regardless of age. (See  <a class="medical medical_review" href="/d/html/16406.html" rel="external">"Definition and staging of chronic kidney disease in adults"</a>.)</p><p>By contrast, many authorities caution against labeling older patients with a stable and normal serum creatinine as having CKD solely based upon an eGFR<sub>creatinine</sub> between 45 and 59 mL/min/1.73 m<sup>2</sup>. The major reasons for this caution are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Estimation of GFR is imprecise and can be inaccurate. A true decrease in GFR in someone with CKD, for example, can be partially cancelled out by a parallel decrease in creatinine generation [<a href="#rid97">97</a>]. In addition, the age variable that is included in the estimating equations can inflate the adverse risks attributed to reduced GFR, particularly in older adults [<a href="#rid88">88</a>]. Many problems associated with estimating GFR using estimation equations apply both to younger and older populations [<a href="#rid74">74</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Because of a decline in GFR with healthy aging, the association of a given eGFR with mortality and ESKD is not identical across the age spectrum  (<a class="graphic graphic_figure graphicRef91447" href="/d/graphic/91447.html" rel="external">figure 2</a>). The relative risk of mortality is substantially less in older compared with younger patients with an eGFR of 45 to 59 mL/min/1.73 m<sup>2</sup>. The development of ESKD is much rarer event in older compared with younger patients with an eGFR of 30 to 59 mL/min/1.73 m<sup>2</sup> and no proteinuria [<a href="#rid115">115</a>]. This issue is discussed above in detail. (See <a class="local">'Mortality and kidney failure risk with CKD from aging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The underlying cause of an age-related decline in eGFR is loss of nephrons from global glomerulosclerosis. While glomerulosclerosis exceeding that expected for age is an important predictor of progressive CKD, age-related global glomerulosclerosis does not appear to contribute to progressive CKD [<a href="#rid29">29</a>].</p><p></p><p>There is concern for both over-diagnosis of CKD in older patients with an eGFR below 60 mL/min/1.73 m<sup>2</sup> and under-diagnosis of CKD in younger patients with eGFR above 60 mL/min/1.73 m<sup>2</sup>. Thus, some have suggested using the upper reference limits for serum creatinine (1.26 mg/dL in males and 1.05 mg/dL in females [111.6 and 93.0 micromol/L, respectively]) to identify those patients who have CKD resulting from GFR reductions that exceed the expected age-related decline. These reference limits are derived using healthy adults in the general population and in healthy kidney donors [<a href="#rid116">116,117</a>]. The upper reference limits for serum creatinine may be slightly higher in African American individuals and slightly lower in Asian individuals, although few studies have assessed reference limits in these populations [<a href="#rid117">117</a>].</p><p>Some have also suggested reporting age-specific lower reference limits for eGFR<sub>creatinine</sub> to prevent the overdiagnosis of CKD in older adults and the underdiagnosis of CKD in young adults [<a href="#rid118">118,119</a>]. These lower reference limits can be calculated from the upper reference limits for serum creatinine  (<a class="graphic graphic_table graphicRef91445" href="/d/graphic/91445.html" rel="external">table 2</a>) [<a href="#rid72">72,73</a>]; however, few studies have assessed reference limits for serum creatinine in older adult populations (&gt;70 years) [<a href="#rid90">90</a>]. In an older adult patient with an eGFR of 45 to 59 mL/min/1.73 m<sup>2</sup> and no albuminuria, we advocate caution in diagnosing CKD (rather than an age-related GFR decline). Approximately one-half of older patients will have an eGFR &lt;60 mL/min/1.73 m<sup>2</sup>, and the relative risks of ESKD and mortality associated with lower eGFR values are substantially less than in younger patients  (<a class="graphic graphic_figure graphicRef91447" href="/d/graphic/91447.html" rel="external">figure 2</a>) [<a href="#rid4">4</a>]. A consortium of several investigators has called for an age-adapted approach to the definition of CKD, as present systems of categorizing CKD do not take into account the age-related decline in GFR with normal, healthy aging [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H9530935"><span class="h2">Medication dosing</span><span class="headingEndMark"> — </span>Dosing with medications that are excreted by glomerular filtration (typically water-soluble medications) should be adjusted to the patient's GFR as indicated by medication dosing guidelines (typically provided by the manufacturer). Historically, most medication dosing guidelines have been developed using the Cockcroft-Gault equation (<a class="calc calc_professional" href="/d/html/13496.html" rel="external">calculator 1</a> and <a class="calc calc_professional" href="/d/html/16104.html" rel="external">calculator 2</a>) [<a href="#rid120">120</a>]. The Cockcroft-Gault equation is not as accurate as the Modification of Diet in Renal Disease (MDRD) study or Chronic Kidney Disease Epidemiology (CKD-EPI) equations for estimating GFR. If GFR is estimated by the MDRD study or CKD-EPI equations, the result must be converted to mL/min by multiplying by the patient's body surface area (<a class="calc calc_professional" href="/d/html/13410.html" rel="external">calculator 3</a>) and dividing by 1.73. Issues related to estimating GFR as it pertains to drug dosing are discussed elsewhere in detail. (See  <a class="medical medical_review" href="/d/html/2359.html" rel="external">"Assessment of kidney function", section on 'Glomerular filtration rate for drug dosing'</a>.)</p><p class="headingAnchor" id="H9530941"><span class="h2">Acute kidney injury</span><span class="headingEndMark"> — </span>Loss of kidney function reserves (functioning nephrons) makes older patients more susceptible to acute kidney injury [<a href="#rid121">121,122</a>]. Medications that have potential kidney toxicity, such as nonsteroidal antiinflammatory drugs (NSAIDs) and radiocontrast agents, should be used cautiously in older patients. (See  <a class="medical medical_review" href="/d/html/7230.html" rel="external">"NSAIDs: Acute kidney injury", section on 'Risk factors'</a>.)</p><p class="headingAnchor" id="H9530947"><span class="h2">Cardiovascular morbidity and mortality risk</span><span class="headingEndMark"> — </span>Age is already included in models that estimate cardiovascular risk. (See  <a class="medical medical_review" href="/d/html/114029.html" rel="external">"Cardiovascular disease risk assessment for primary prevention: Risk calculators"</a>.)</p><p>Addition of eGFR<sub>creatinine </sub>to cardiovascular risk models does <strong>not</strong> meaningfully improve risk prediction over conventional risk stratification models [<a href="#rid123">123-125</a>]. In addition, the inclusion of cystatin C with conventional factors in cardiovascular risk assessment only minimally improves prediction over conventional risk factors alone [<a href="#rid126">126</a>]. Cystatin C might contribute to the prediction of cardiovascular outcomes along non-GFR biological pathways, such as inflammation and atherosclerosis [<a href="#rid94">94-96</a>]. The issue of CKD as a risk factor for cardiovascular disease is presented in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/7190.html" rel="external">"Chronic kidney disease and coronary heart disease"</a> and  <a class="medical medical_review" href="/d/html/7190.html" rel="external">"Chronic kidney disease and coronary heart disease", section on 'CKD as a CHD risk equivalent'</a>.)</p><p class="headingAnchor" id="H9530953"><span class="h2">End-stage kidney disease</span><span class="headingEndMark"> — </span>CKD from aging alone does not, by itself, progress to kidney failure, even in very old persons [<a href="#rid127">127</a>]. A validated calculator has been developed to estimate the risk of kidney failure [<a href="#rid128">128,129</a>]. Like most prior kidney failure risk models, both age and eGFR<sub>creatinine</sub> were included in the prediction model. While lower eGFR<sub>creatinine</sub> is associated with increased risk of kidney failure, older age is actually associated with a lower risk of kidney failure. This occurs because, at the same eGFR<sub>creatinine</sub>, older patients as compared with younger patients are more likely to die before developing ESKD [<a href="#rid130">130</a>]. Kidney failure prediction models can help inform decisions about the need to prepare for dialysis in older adult patients (eg, placement of an arteriovenous fistula). These models can also reassure older patients with only age-related reductions in eGFR<sub>creatinine</sub> that their risk of progression to ESKD is very low. As an example, a 70-year-old female who has been diagnosed with "CKD" based on an isolated eGFR of 50 mL/min/1.73 m<sup>2</sup> will have &lt;1 percent risk of ESKD in the next five years.</p><p class="headingAnchor" id="H9530959"><span class="h2">Living kidney donor evaluation</span><span class="headingEndMark"> — </span>There are substantial changes in the microanatomy (glomerulosclerosis), macroanatomy (cortical volume loss), and kidney function (GFR decline) with older age, even among healthy adults. Even a kidney donor in his or her thirties will have more nephrosclerosis on kidney biopsy than a kidney donor in his or her twenties [<a href="#rid14">14</a>]. Living donors have been reported to have similar long-term mortality and kidney failure risk compared with age-matched controls who do not donate a kidney, despite the fact that a postdonation eGFR &lt;60 mL/min/1.73 m<sup>2</sup> occurs in more than 60 percent of donors older than 50 years [<a href="#rid131">131-133</a>]. In particular, a study of 219 living donors aged ≥70 years found a <strong>lower</strong> risk of mortality compared with age- and comorbidity-matched controls [<a href="#rid133">133</a>]. Another study of 3368 older living donors (mean age 59 years) found no increased risk of death compared with older healthy matched controls [<a href="#rid134">134</a>]. Conversely, a study of 1901 living donors in Norway found an increased long-term risk for ESKD and mortality with kidney donation, possibly because the age-matched controls in that study were healthier than age-matched controls in prior studies [<a href="#rid135">135</a>]. Whether this risk they detected differs between older and younger donors was not reported.</p><p>Many transplant programs only require the predonation GFR to be appropriate for the donor's age  (<a class="graphic graphic_table graphicRef91445" href="/d/graphic/91445.html" rel="external">table 2</a>) and permit certain CKD risk factors (such as mild hypertension) to be present in older donors without rejecting them as candidates [<a href="#rid136">136</a>]. Another approach is to use a calculator to estimate the risk of ESKD in potential donors; older donors have a much lower risk of ESKD than younger donors at the same eGFR [<a href="#rid137">137</a>]. From the recipient's perspective, an older allograft (donated kidney) is associated with somewhat higher rates of graft loss [<a href="#rid133">133</a>], and this may be related to the increased nephrosclerosis present with aging with a resultant lower nephron number in the allograft (see <a class="local">'Structural changes of the kidneys with aging'</a> above). The use of an age-calibrated measured GFR may improve the living donor-selection process [<a href="#rid138">138,139</a>].</p><p class="headingAnchor" id="H9530965"><span class="h2">Counseling patients with CKD due to normal age-related GFR declines</span><span class="headingEndMark"> — </span>In older adults who are diagnosed with age-related "chronic kidney disease (CKD)," a careful explanation is warranted to reassure the patient that a decline in GFR within the range expected for normal aging will have little, if any, effect on his or her life expectancy. Although they may be at higher risk for ESKD because of lower functional reserve (fewer functioning nephrons), this is still a relatively rare event, particularly in older adults with an eGFR of 45 to 59 mL/min/1.73 m<sup>2</sup> and normal albuminuria (CKD stage G3a/a1 in the KDIGO classification system) [<a href="#rid140">140</a>]. Context is particularly relevant, as there are no known therapies that can reverse the age-related decline in GFR. It may also be helpful to discuss that senescence occurs in many other organs such as the skin and the lungs. (See  <a class="medical medical_review" href="/d/html/5573.html" rel="external">"Overview of benign lesions of the skin"</a> and  <a class="medical medical_review" href="/d/html/6971.html" rel="external">"Selecting reference values for pulmonary function tests"</a>.)</p><p class="headingAnchor" id="H9530978"><span class="h1">ALBUMINURIA</span><span class="headingEndMark"> — </span>Although urine albumin excretion increases with age in the general population [<a href="#rid141">141</a>], 24-hour urine albumin excretion does <strong>not</strong> inevitably increase with age in healthy adults, provided few or no comorbidities are present [<a href="#rid14">14</a>]. Thus, albuminuria may be a useful marker for distinguishing normal aging from another etiology of chronic kidney disease (CKD).</p><p>However, the random first morning urine albumin-to-creatinine ratio (UACR), which is more widely used in clinical practice than a 24-hour urine collection, is more likely to give a falsely elevated result in an aged population. Unlike the 24-hour urine albumin excretion, UACR usually increases with healthy aging due in part to age-related reductions in muscle mass that result in reduced creatinine generation and excretion [<a href="#rid88">88,142,143</a>]. If a random or morning UACR is used to assess albuminuria in older adults, multiplying the UACR by the <strong>expected</strong> 24-hour urine creatinine (according to age, sex, body weight, and race) may improve the accuracy of the test for detecting an abnormally high albumin excretion. The expected 24-hour urine creatinine can be calculated from one of several formulas [<a href="#rid144">144,145</a>].</p><p class="headingAnchor" id="H9530990"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview </strong>– In 1999, glomerular filtration rate (GFR)-estimating equations started to replace serum creatinine for the evaluation of kidney function. Since that time, more and more older adults have been identified as having acute or chronic kidney disease (CKD), and the prevalence of diagnosed kidney disease in this population has increased. Approximately one-half of adults over the age of 70 years now have a measured or estimated GFR (eGFR) &lt;60 mL/min/1.73 m<sup>2</sup>, a threshold often used to diagnose CKD. This higher prevalence of diagnosed CKD is not simply due to increased recognition of diseases that tend to cluster in older adults. Rather, much of the increased rate of CKD diagnoses in the older adult population results from the normal structural and functional changes that occur in the kidney with aging. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Normal aging versus chronic disease </strong>– It can sometimes be difficult to distinguish the structural and functional changes of a kidney affected by a specific preventable or treatable disease from those of a kidney undergoing the inevitable consequences of aging. However, even if the reduction in function is not preventable or treatable, senescent changes in the kidney are relevant and important to managing older patients. Specifically, loss of kidney function reserves with aging has the following clinical significance (see <a class="local">'Normal aging versus chronic disease'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>More advanced disease if a new specific nephropathy, such as diabetic nephropathy or vasculitis, develops</p><p class="bulletIndent2"><span class="glyph">•</span>Increased susceptibility to acute kidney injury</p><p class="bulletIndent2"><span class="glyph">•</span>Toxic accumulation of medications cleared by the kidney</p><p class="bulletIndent2"><span class="glyph">•</span>The need for age-appropriate criteria in the selection of living kidney donors</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Structural changes with aging </strong>– Various structural changes occur with aging, including (see <a class="local">'Structural changes of the kidneys with aging'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nephrosclerosis (see <a class="local">'Nephrosclerosis'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Decline in nephron number (see <a class="local">'Nephron number in aging kidneys'</a> above) </p><p class="bulletIndent2"><span class="glyph">•</span>Decreased kidney cortical volume (see <a class="local">'Kidney volume'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Development of kidney cysts (see <a class="local">'Kidney cysts and tumors'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Glomerular volume and single-nephron GFR remain stable (see <a class="local">'Mechanistic basis for GFR decline with aging'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Functional changes with aging </strong>– Rates of GFR decline with aging follow a fairly normal (Gaussian) distribution, suggesting that it is primarily driven by a physiological process. Not only does the lower reference limit for GFR decrease with age, but the upper reference limit also decreases with age, consistent with a universal or near-universal decline in kidney function  (<a class="graphic graphic_table graphicRef91445" href="/d/graphic/91445.html" rel="external">table 2</a>). (See <a class="local">'GFR declines with normal aging'</a> above.)</p><p></p><p class="bulletIndent1">The Kidney Disease Improving Global Outcomes (KDIGO) 2012 guidelines define and stage CKD by levels of GFR and albuminuria  (<a class="graphic graphic_table graphicRef70597" href="/d/graphic/70597.html" rel="external">table 3</a>). Approximately half of adults older than 70 years are found to have "CKD" as determined by a measured or estimated GFR &lt;60 mL/min/1.73 m<sup>2</sup>. Often, a specific disease process for a GFR reduction to &lt;60 mL/min/1.73 m<sup>2</sup> in older adults cannot be identified (other than normal aging). (See <a class="local">'High proportion of older adults with reduced GFR'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Confirming CKD in older adults </strong>– Uncertainty regarding the diagnosis of CKD in older adults may exist, particularly when the patient's eGFR<sub>creatinine</sub> is 45 to 59 mL/min/1.73 m<sup>2</sup>, when other evidence of CKD such as albuminuria is lacking, or when the muscle mass is higher than average for the patient's age. When such uncertainty exists regarding the diagnosis of CKD based upon eGFR<sub>creatinine</sub>, a urinary creatinine clearance or direct GFR measurement can further assess the kidney function of older adult patients. This may be particularly important when an accurate GFR assessment is needed for an older patient who wants to donate a kidney. In contrast to KDIGO suggestions, we do not recommend use of cystatin C to confirm a diagnosis of CKD in older adults. (See <a class="local">'When and how to confirm CKD in older adults'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical significance of the aging kidney </strong>– There are several important issues in the management of patients with age-related changes in kidney structure and function. These include (see <a class="local">'Clinical significance of the aging kidney'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There are no proven therapies to halt or reverse age-related declines in GFR. Any therapy aimed at raising the GFR by causing the remaining functional nephrons to filter more may actually be harmful rather than beneficial to the kidney. Hypertrophy and hyperfiltration of functional glomeruli in animals, for example, can lead to further glomerulosclerosis. (See  <a class="medical medical_review" href="/d/html/7181.html" rel="external">"Secondary factors and progression of chronic kidney disease"</a> and  <a class="medical medical_review" href="/d/html/7181.html" rel="external">"Secondary factors and progression of chronic kidney disease", section on 'Intraglomerular hypertension and glomerular hypertrophy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with age-related reductions in GFR require medication dose adjustments. (See <a class="local">'Medication dosing'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The loss of functioning nephrons associated with normal aging puts older adults at higher risk for acute kidney injury. (See <a class="local">'Acute kidney injury'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A mild reduction in eGFR with aging does <strong>not</strong> substantially improve the assessment of cardiovascular risk over conventional predictors and does <strong>not</strong> indicate a high risk of end-stage kidney disease (ESKD)  (<a class="graphic graphic_figure graphicRef91447" href="/d/graphic/91447.html" rel="external">figure 2</a>). (See <a class="local">'Cardiovascular morbidity and mortality risk'</a> above and <a class="local">'End-stage kidney disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Age-related declines in GFR do <strong>not</strong> typically prevent older adults from becoming living kidney donors. (See <a class="local">'Living kidney donor evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Overall, the typical age-related declines in GFR have little, if any, effect on life expectancy or the future need for dialysis, and this point is important in discussions with older adult patients. (See <a class="local">'Counseling patients with CKD due to normal age-related GFR declines'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ebert N, Jakob O, Gaedeke J, et al. Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study. Nephrol Dial Transplant 2017; 32:997.</a></li><li><a class="nounderline abstract_t">National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1.</a></li><li><a class="nounderline abstract_t">KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3:136.</a></li><li><a class="nounderline abstract_t">Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int 2012; 82:270.</a></li><li><a class="nounderline abstract_t">Levey AS, Inker LA, Coresh J. "Should the definition of CKD be changed to include age-adapted GFR criteria?": Con: the evaluation and management of CKD, not the definition, should be age-adapted. Kidney Int 2020; 97:37.</a></li><li><a class="nounderline abstract_t">Coresh J, Gansevoort RT, CKD Prognosis Consortium, et al. Current CKD Definition Takes into Account Both Relative and Absolute Risk. J Am Soc Nephrol 2020; 31:447.</a></li><li><a class="nounderline abstract_t">Delanaye P, Jager KJ, Bökenkamp A, et al. CKD: A Call for an Age-Adapted Definition. J Am Soc Nephrol 2019; 30:1785.</a></li><li><a class="nounderline abstract_t">Rule AD, Jager KJ, van den Brand JAJG, Delanaye P. Authors' Reply. J Am Soc Nephrol 2020; 31:448.</a></li><li><a class="nounderline abstract_t">Glassock RJ, Delanaye P, Rule AD. Should the definition of CKD be changed to include age-adapted GFR criteria? YES. Kidney Int 2020; 97:34.</a></li><li><a class="nounderline abstract_t">Rovin BH. Do kidneys grow old gracefully? Kidney Int 2020; 97:40.</a></li><li><a class="nounderline abstract_t">O'Hare AM, Rodriguez RA, Rule AD. Overdiagnosis of Chronic Kidney Disease in Older Adults-An Inconvenient Truth. JAMA Intern Med 2021; 181:1366.</a></li><li><a class="nounderline abstract_t">Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63:1046.</a></li><li><a class="nounderline abstract_t">Kasiske BL, Umen AJ. The influence of age, sex, race, and body habitus on kidney weight in humans. Arch Pathol Lab Med 1986; 110:55.</a></li><li><a class="nounderline abstract_t">Rule AD, Amer H, Cornell LD, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 152:561.</a></li><li><a class="nounderline abstract_t">Martin JE, Sheaff MT. Renal ageing. J Pathol 2007; 211:198.</a></li><li class="breakAll">Zhou X, Zoltona G, Silva F. Anatomical Changes in the Aging Kidney. In: The Aging Kidney in Health and Disease, Macias Nunez J, JS C, Oreopoulos D (Eds), Springer Science+Business Media, LLC, New York 2008. p.39.</li><li><a class="nounderline abstract_t">Wiggins JE, Goyal M, Sanden SK, et al. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005; 16:2953.</a></li><li><a class="nounderline abstract_t">Kubo M, Kiyohara Y, Kato I, et al. Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study. Kidney Int 2003; 63:1508.</a></li><li><a class="nounderline abstract_t">Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992; 232:194.</a></li><li><a class="nounderline abstract_t">Hoy WE, Douglas-Denton RN, Hughson MD, et al. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 2003; :S31.</a></li><li><a class="nounderline abstract_t">Mancilla E, Avila-Casado C, Uribe-Uribe N, et al. Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities. Transplantation 2008; 86:1684.</a></li><li><a class="nounderline abstract_t">Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study. Virchows Arch A Pathol Anat Histol 1980; 387:271.</a></li><li><a class="nounderline abstract_t">Heylen L, Thienpont B, Busschaert P, et al. Age-related changes in DNA methylation affect renal histology and post-transplant fibrosis. Kidney Int 2019; 96:1195.</a></li><li><a class="nounderline abstract_t">Vazquez Martul E, Veiga Barreiro A. Importance of kidney biopsy in graft selection. Transplant Proc 2003; 35:1658.</a></li><li><a class="nounderline abstract_t">Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80:227.</a></li><li><a class="nounderline abstract_t">Darmady EM, Offer J, Woodhouse MA. The parameters of the ageing kidney. J Pathol 1973; 109:195.</a></li><li><a class="nounderline abstract_t">Hodgin JB, Bitzer M, Wickman L, et al. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. J Am Soc Nephrol 2015; 26:3162.</a></li><li><a class="nounderline abstract_t">Kremers WK, Denic A, Lieske JC, et al. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transplant 2015; 30:2034.</a></li><li><a class="nounderline abstract_t">Hommos MS, Zeng C, Liu Z, et al. Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. Kidney Int 2018; 93:1175.</a></li><li><a class="nounderline abstract_t">Srivastava A, Palsson R, Kaze AD, et al. The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. J Am Soc Nephrol 2018; 29:2213.</a></li><li><a class="nounderline abstract_t">Denic A, Ricaurte L, Lopez CL, et al. Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney. J Am Soc Nephrol 2019; 30:1471.</a></li><li><a class="nounderline abstract_t">Fulladosa X, Moreso F, Narváez JA, et al. Estimation of total glomerular number in stable renal transplants. J Am Soc Nephrol 2003; 14:2662.</a></li><li><a class="nounderline abstract_t">Tan JC, Busque S, Workeneh B, et al. Effects of aging on glomerular function and number in living kidney donors. Kidney Int 2010; 78:686.</a></li><li><a class="nounderline abstract_t">Tan JC, Workeneh B, Busque S, et al. Glomerular function, structure, and number in renal allografts from older deceased donors. J Am Soc Nephrol 2009; 20:181.</a></li><li><a class="nounderline abstract_t">Denic A, Lieske JC, Chakkera HA, et al. The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. J Am Soc Nephrol 2017; 28:313.</a></li><li><a class="nounderline abstract_t">Ricaurte Archila L, Denic A, Mullan AF, et al. A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor. J Am Soc Nephrol 2021; 32:2623.</a></li><li><a class="nounderline abstract_t">Vikse BE, Irgens LM, Leivestad T, et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008; 19:151.</a></li><li><a class="nounderline abstract_t">White SL, Perkovic V, Cass A, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 2009; 54:248.</a></li><li><a class="nounderline abstract_t">Reyes L, Mañalich R. Long-term consequences of low birth weight. Kidney Int Suppl 2005; :S107.</a></li><li><a class="nounderline abstract_t">Luyckx VA, Bertram JF, Brenner BM, et al. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 2013; 382:273.</a></li><li><a class="nounderline abstract_t">Hayslett JP, Kashgarian M, Epstein FH. Functional correlates of compensatory renal hypertrophy. J Clin Invest 1968; 47:774.</a></li><li><a class="nounderline abstract_t">Sigmon DH, Gonzalez-Feldman E, Cavasin MA, et al. Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy. J Am Soc Nephrol 2004; 15:1413.</a></li><li><a class="nounderline abstract_t">Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004; 286:F8.</a></li><li><a class="nounderline abstract_t">Abdi R, Slakey D, Kittur D, Racusen LC. Heterogeneity of glomerular size in normal donor kidneys: impact of race. Am J Kidney Dis 1998; 32:43.</a></li><li><a class="nounderline abstract_t">Herts BR, Sharma N, Lieber M, et al. Estimating glomerular filtration rate in kidney donors: a model constructed with renal volume measurements from donor CT scans. Radiology 2009; 252:109.</a></li><li><a class="nounderline abstract_t">Rule AD, Semret MH, Amer H, et al. Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc 2011; 86:282.</a></li><li><a class="nounderline abstract_t">Elsherbiny HE, Alexander MP, Kremers WK, et al. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Clin J Am Soc Nephrol 2014; 9:1892.</a></li><li><a class="nounderline abstract_t">Denic A, Alexander MP, Kaushik V, et al. Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults. Am J Kidney Dis 2016; 68:58.</a></li><li><a class="nounderline abstract_t">Goyal VK. Changes with age in the human kidney. Exp Gerontol 1982; 17:321.</a></li><li><a class="nounderline abstract_t">Denic A, Mathew J, Lerman LO, et al. Single-Nephron Glomerular Filtration Rate in Healthy Adults. N Engl J Med 2017; 376:2349.</a></li><li><a class="nounderline abstract_t">Luyckx VA, Rule AD, Tuttle KR, et al. Nephron overload as a therapeutic target to maximize kidney lifespan. Nat Rev Nephrol 2022; 18:171.</a></li><li><a class="nounderline abstract_t">Gourtsoyiannis N, Prassopoulos P, Cavouras D, Pantelidis N. The thickness of the renal parenchyma decreases with age: a CT study of 360 patients. AJR Am J Roentgenol 1990; 155:541.</a></li><li><a class="nounderline abstract_t">Emamian SA, Nielsen MB, Pedersen JF, Ytte L. Kidney dimensions at sonography: correlation with age, sex, and habitus in 665 adult volunteers. AJR Am J Roentgenol 1993; 160:83.</a></li><li><a class="nounderline abstract_t">Glodny B, Unterholzner V, Taferner B, et al. Normal kidney size and its influencing factors - a 64-slice MDCT study of 1.040 asymptomatic patients. BMC Urol 2009; 9:19.</a></li><li><a class="nounderline abstract_t">Bax L, van der Graaf Y, Rabelink AJ, et al. Influence of atherosclerosis on age-related changes in renal size and function. Eur J Clin Invest 2003; 33:34.</a></li><li><a class="nounderline abstract_t">Piras D, Masala M, Delitala A, et al. Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population. Nephrol Dial Transplant 2020; 35:640.</a></li><li><a class="nounderline abstract_t">Roseman DA, Hwang SJ, Oyama-Manabe N, et al. Clinical associations of total kidney volume: the Framingham Heart Study. Nephrol Dial Transplant 2017; 32:1344.</a></li><li><a class="nounderline abstract_t">Johnson S, Rishi R, Andone A, et al. Determinants and functional significance of renal parenchymal volume in adults. Clin J Am Soc Nephrol 2011; 6:70.</a></li><li><a class="nounderline abstract_t">Jeon HG, Lee SR, Joo DJ, et al. Predictors of kidney volume change and delayed kidney function recovery after donor nephrectomy. J Urol 2010; 184:1057.</a></li><li><a class="nounderline abstract_t">Wang X, Vrtiska TJ, Avula RT, et al. Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int 2014; 85:677.</a></li><li><a class="nounderline abstract_t">McLachlan MS. The ageing kidney. Lancet 1978; 2:143.</a></li><li><a class="nounderline abstract_t">Newbold KM, Sandison A, Howie AJ. Comparison of size of juxtamedullary and outer cortical glomeruli in normal adult kidney. Virchows Arch A Pathol Anat Histopathol 1992; 420:127.</a></li><li><a class="nounderline abstract_t">Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of the different races. Gerontologia 1971; 17:87.</a></li><li><a class="nounderline abstract_t">Rao UV, Wagner HN Jr. Normal weights of human organs. Radiology 1972; 102:337.</a></li><li><a class="nounderline abstract_t">McLachlan M, Wasserman P. Changes in sizes and distensibility of the aging kidney. Br J Radiol 1981; 54:488.</a></li><li><a class="nounderline abstract_t">Eknoyan G. A clinical view of simple and complex renal cysts. J Am Soc Nephrol 2009; 20:1874.</a></li><li><a class="nounderline abstract_t">Rule AD, Sasiwimonphan K, Lieske JC, et al. Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. Am J Kidney Dis 2012; 59:611.</a></li><li><a class="nounderline abstract_t">Baert L, Steg A. Is the diverticulum of the distal and collecting tubules a preliminary stage of the simple cyst in the adult? J Urol 1977; 118:707.</a></li><li><a class="nounderline abstract_t">Ravine D, Gibson RN, Walker RG, et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343:824.</a></li><li><a class="nounderline abstract_t">Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 2011; 26:2695.</a></li><li><a class="nounderline abstract_t">Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:278.</a></li><li><a class="nounderline abstract_t">Poggio ED, Rule AD, Tanchanco R, et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 2009; 75:1079.</a></li><li><a class="nounderline abstract_t">Wetzels JF, Kiemeney LA, Swinkels DW, et al. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007; 72:632.</a></li><li><a class="nounderline abstract_t">Pottel H, Delanaye P, Weekers L, et al. Age-dependent reference intervals for estimated and measured glomerular filtration rate. Clin Kidney J 2017; 10:545.</a></li><li><a class="nounderline abstract_t">Chakkera HA, Denic A, Kremers WK, et al. Comparison of high glomerular filtration rate thresholds for identifying hyperfiltration. Nephrol Dial Transplant 2020; 35:1017.</a></li><li><a class="nounderline abstract_t">Eriksen BO, Palsson R, Ebert N, et al. GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts. J Am Soc Nephrol 2020; 31:1602.</a></li><li><a class="nounderline abstract_t">Eriksen BO, Løchen ML, Arntzen KA, et al. Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population. Kidney Int 2014; 86:146.</a></li><li><a class="nounderline abstract_t">Hollenberg NK, Fisher ND, McCullough ML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens 2009; 3:105.</a></li><li><a class="nounderline abstract_t">Hollenberg NK, Martinez G, McCullough M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension 1997; 29:171.</a></li><li><a class="nounderline abstract_t">Hollenberg NK, Rivera A, Meinking T, et al. Age, renal perfusion and function in island-dwelling indigenous Kuna Amerinds of Panama. Nephron 1999; 82:131.</a></li><li><a class="nounderline abstract_t">Schaeffner ES, Ebert N, Kuhlmann MK, et al. Age and the Course of GFR in Persons Aged 70 and Above. Clin J Am Soc Nephrol 2022; 17:1119.</a></li><li><a class="nounderline abstract_t">Rule AD, Cornell LD, Poggio ED. Senile nephrosclerosis--does it explain the decline in glomerular filtration rate with aging? Nephron Physiol 2011; 119 Suppl 1:p6.</a></li><li><a class="nounderline abstract_t">Lew SW, Bosch JP. Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease. J Am Soc Nephrol 1991; 2:856.</a></li><li><a class="nounderline abstract_t">Daugirdas JT, Meyer K, Greene T, et al. Scaling of measured glomerular filtration rate in kidney donor candidates by anthropometric estimates of body surface area, body water, metabolic rate, or liver size. Clin J Am Soc Nephrol 2009; 4:1575.</a></li><li><a class="nounderline abstract_t">Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157:471.</a></li><li><a class="nounderline abstract_t">Pottel H, Hoste L, Yayo E, Delanaye P. Glomerular Filtration Rate in Healthy Living Potential Kidney Donors: A Meta-Analysis Supporting the Construction of the Full Age Spectrum Equation. Nephron 2017; 135:105.</a></li><li><a class="nounderline abstract_t">Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604.</a></li><li><a class="nounderline abstract_t">Rule AD, Bailey KR, Schwartz GL, et al. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009; 75:1071.</a></li><li><a class="nounderline abstract_t">Rule AD, Gussak HM, Pond GR, et al. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 2004; 43:112.</a></li><li><a class="nounderline abstract_t">Pottel H, Vrydags N, Mahieu B, et al. Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008; 396:49.</a></li><li><a class="nounderline abstract_t">Anastasio P, Cirillo M, Spitali L, et al. Level of hydration and renal function in healthy humans. Kidney Int 2001; 60:748.</a></li><li><a class="nounderline abstract_t">Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20.</a></li><li><a class="nounderline abstract_t">Rule AD, Glassock RJ. GFR estimating equations: getting closer to the truth? Clin J Am Soc Nephrol 2013; 8:1414.</a></li><li><a class="nounderline abstract_t">Lafarge JC, Naour N, Clément K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 2010; 92:1580.</a></li><li><a class="nounderline abstract_t">Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-β and role played in cell migration. J Neuroimmunol 2011; 232:200.</a></li><li><a class="nounderline abstract_t">Naour N, Fellahi S, Renucci JF, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009; 17:2121.</a></li><li><a class="nounderline abstract_t">Rule AD, Bailey KR, Lieske JC, et al. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 2013; 83:1169.</a></li><li><a class="nounderline abstract_t">Mathisen UD, Melsom T, Ingebretsen OC, et al. Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 2011; 22:927.</a></li><li><a class="nounderline abstract_t">Pavkov ME, Knowler WC, Hanson RL, et al. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy. Am J Kidney Dis 2013; 62:33.</a></li><li><a class="nounderline abstract_t">Bhavsar NA, Appel LJ, Kusek JW, et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 2011; 58:886.</a></li><li><a class="nounderline abstract_t">Hallan SI, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308:2349.</a></li><li><a class="nounderline abstract_t">Warnock DG, Delanaye P, Glassock RJ. Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria. Nephron 2017; 136:292.</a></li><li><a class="nounderline abstract_t">Malmgren L, McGuigan FE, Berglundh S, et al. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women. Nephron 2015; 130:245.</a></li><li><a class="nounderline abstract_t">Jonsson AJ, Lund SH, Eriksen BO, et al. The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds. Kidney Int 2020; 98:1286.</a></li><li><a class="nounderline abstract_t">Liu P, Quinn RR, Lam NN, et al. Accounting for Age in the Definition of Chronic Kidney Disease. JAMA Intern Med 2021; 181:1359.</a></li><li><a class="nounderline abstract_t">Tian Y, Riazi S, Khan O, et al. Renal ENaC subunit, Na-K-2Cl and Na-Cl cotransporter abundances in aged, water-restricted F344 x Brown Norway rats. Kidney Int 2006; 69:304.</a></li><li><a class="nounderline abstract_t">Epstein M. Aging and the kidney. J Am Soc Nephrol 1996; 7:1106.</a></li><li><a class="nounderline abstract_t">Kaysen GA, Myers BD. The aging kidney. Clin Geriatr Med 1985; 1:207.</a></li><li><a class="nounderline abstract_t">Zhou XJ, Rakheja D, Yu X, et al. The aging kidney. Kidney Int 2008; 74:710.</a></li><li><a class="nounderline abstract_t">Esposito C, Dal Canton A. Functional changes in the aging kidney. J Nephrol 2010; 23 Suppl 15:S41.</a></li><li><a class="nounderline abstract_t">Combet S, Gouraud S, Gobin R, et al. Aquaporin-2 downregulation in kidney medulla of aging rats is posttranscriptional and is abolished by water deprivation. Am J Physiol Renal Physiol 2008; 294:F1408.</a></li><li><a class="nounderline abstract_t">Rodenburg EM, Hoorn EJ, Ruiter R, et al. Thiazide-associated hyponatremia: a population-based study. Am J Kidney Dis 2013; 62:67.</a></li><li><a class="nounderline abstract_t">Michelis MF. Hyperkalemia in the elderly. Am J Kidney Dis 1990; 16:296.</a></li><li><a class="nounderline abstract_t">O'Hare AM, Hotchkiss JR, Kurella Tamura M, et al. Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults. JAMA Intern Med 2014; 174:391.</a></li><li><a class="nounderline abstract_t">Obi Y, Kimura T, Nagasawa Y, et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol 2010; 5:1558.</a></li><li><a class="nounderline abstract_t">Rule AD, Larson TS. Do we need another equation to estimate GFR from serum creatinine in renal allograft recipients? Nephrol Dial Transplant 2008; 23:2427.</a></li><li><a class="nounderline abstract_t">Pottel H, Hoste L, Delanaye P, et al. Demystifying ethnic/sex differences in kidney function: is the difference in (estimating) glomerular filtration rate or in serum creatinine concentration? Clin Chim Acta 2012; 413:1612.</a></li><li><a class="nounderline abstract_t">Benghanem Gharbi M, Elseviers M, Zamd M, et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD. Kidney Int 2016; 89:1363.</a></li><li><a class="nounderline abstract_t">Pottel H, Hoste L, Delanaye P. Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m(2). Pediatr Nephrol 2015; 30:821.</a></li><li><a class="nounderline abstract_t">Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31.</a></li><li><a class="nounderline abstract_t">James MT, Hemmelgarn BR, Wiebe N, et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 2010; 376:2096.</a></li><li><a class="nounderline abstract_t">Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80:93.</a></li><li><a class="nounderline abstract_t">Clase CM, Gao P, Tobe SW, et al. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study. Ann Intern Med 2011; 154:310.</a></li><li><a class="nounderline abstract_t">Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010; 341:c4986.</a></li><li><a class="nounderline abstract_t">Drawz PE, Baraniuk S, Davis BR, et al. Cardiovascular risk assessment: addition of CKD and race to the Framingham equation. Am Heart J 2012; 164:925.</a></li><li><a class="nounderline abstract_t">Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302:49.</a></li><li><a class="nounderline abstract_t">Fehrman-Ekholm I, Skeppholm L. Renal function in the elderly (&gt;70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 2004; 38:73.</a></li><li><a class="nounderline abstract_t">Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305:1553.</a></li><li><a class="nounderline abstract_t">Tangri N, Grams ME, Levey AS, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA 2016; 315:164.</a></li><li><a class="nounderline abstract_t">O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18:2758.</a></li><li><a class="nounderline abstract_t">Fehrman-Ekholm I, Nordén G, Lennerling A, et al. Incidence of end-stage renal disease among live kidney donors. Transplantation 2006; 82:1646.</a></li><li><a class="nounderline abstract_t">Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360:459.</a></li><li><a class="nounderline abstract_t">Berger JC, Muzaale AD, James N, et al. Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol 2011; 6:2887.</a></li><li><a class="nounderline abstract_t">Reese PP, Bloom RD, Feldman HI, et al. Mortality and cardiovascular disease among older live kidney donors. Am J Transplant 2014; 14:1853.</a></li><li><a class="nounderline abstract_t">Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int 2014; 86:162.</a></li><li><a class="nounderline abstract_t">Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 2005; 16:2098.</a></li><li><a class="nounderline abstract_t">Grams ME, Sang Y, Levey AS, et al. Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med 2016; 374:411.</a></li><li><a class="nounderline abstract_t">Gaillard F, Courbebaisse M, Kamar N, et al. The age-calibrated measured glomerular filtration rate improves living kidney donation selection process. Kidney Int 2018; 94:616.</a></li><li><a class="nounderline abstract_t">Glassock RJ. Evaluation of living donors: quo vadis for GFR criteria? Kidney Int 2019; 95:738.</a></li><li><a class="nounderline abstract_t">Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333:1047.</a></li><li><a class="nounderline abstract_t">Tanaka S, Takase H, Dohi Y, Kimura G. The prevalence and characteristics of microalbuminuria in the general population: a cross-sectional study. BMC Res Notes 2013; 6:256.</a></li><li><a class="nounderline abstract_t">Kestenbaum B, de Boer IH. Urine albumin-to-creatinine ratio: what's in a number? J Am Soc Nephrol 2010; 21:1243.</a></li><li><a class="nounderline abstract_t">Lambers Heerspink HJ, Gansevoort RT, Brenner BM, et al. Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol 2010; 21:1355.</a></li><li><a class="nounderline abstract_t">Fotheringham J, Campbell MJ, Fogarty DG, et al. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis 2014; 63:405.</a></li><li><a class="nounderline abstract_t">Ix JH, Wassel CL, Stevens LA, et al. Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clin J Am Soc Nephrol 2011; 6:184.</a></li></ol></div><div id="topicVersionRevision">Topic 89217 Version 13.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27190381" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11904577" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22437416" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31901355" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : "Should the definition of CKD be changed to include age-adapted GFR criteria?": Con: the evaluation and management of CKD, not the definition, should be age-adapted.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31871274" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Current CKD Definition Takes into Account Both Relative and Absolute Risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31506289" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : CKD: A Call for an Age-Adapted Definition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31871273" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Authors' Reply.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31901354" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Should the definition of CKD be changed to include age-adapted GFR criteria? YES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31901356" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Do kidneys grow old gracefully?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34459870" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Overdiagnosis of Chronic Kidney Disease in Older Adults-An Inconvenient Truth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18786983" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3753571" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The influence of age, sex, race, and body habitus on kidney weight in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20439574" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The association between age and nephrosclerosis on renal biopsy among healthy adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17200944" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Renal ageing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17200944" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Renal ageing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16120818" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12631368" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1546799" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Glomerular number and size in relation to age, kidney weight, and body surface in normal man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12864872" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19104405" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7006195" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31530476" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Age-related changes in DNA methylation affect renal histology and post-transplant fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12962746" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Importance of kidney biopsy in graft selection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/51591" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Age-related incidence of sclerotic glomeruli in human kidneys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4719771" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The parameters of the ageing kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26038526" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25888387" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29273332" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29866798" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31278193" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14514746" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Estimation of total glomerular number in stable renal transplants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20463656" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effects of aging on glomerular function and number in living kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18815243" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Glomerular function, structure, and number in renal allografts from older deceased donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27401688" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34531177" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18057216" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Low birth weight increases risk for end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19339091" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16014086" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Long-term consequences of low birth weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23727166" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5641618" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Functional correlates of compensatory renal hypertrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15153552" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14656757" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9669422" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Heterogeneity of glomerular size in normal donor kidneys: impact of race.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19435940" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Estimating glomerular filtration rate in kidney donors: a model constructed with renal volume measurements from donor CT scans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21454731" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25318758" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26857648" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7169092" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Changes with age in the human kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28614683" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Single-Nephron Glomerular Filtration Rate in Healthy Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34880459" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Nephron overload as a therapeutic target to maximize kidney lifespan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2117353" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The thickness of the renal parenchyma decreases with age: a CT study of 360 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8416654" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Kidney dimensions at sonography: correlation with age, sex, and habitus in 665 adult volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20030823" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Normal kidney size and its influencing factors - a 64-slice MDCT study of 1.040 asymptomatic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12492450" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Influence of atherosclerosis on age-related changes in renal size and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30169833" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27325252" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Clinical associations of total kidney volume: the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20847095" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Determinants and functional significance of renal parenchymal volume in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20643435" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Predictors of kidney volume change and delayed kidney function recovery after donor nephrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24067437" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/78337" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The ageing kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1549901" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Comparison of size of juxtamedullary and outer cortical glomeruli in normal adult kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5093734" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Age changes in the human kidney of the different races.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5009936" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Normal weights of human organs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7237026" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Changes in sizes and distensibility of the aging kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18776117" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : A clinical view of simple and complex renal cysts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22398108" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/410950" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Is the diverticulum of the distal and collecting tubules a preliminary stage of the simple cyst in the adult?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7908078" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21285126" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Clinical characteristics of potential kidney donors with asymptomatic kidney stones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3989190" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Longitudinal studies on the rate of decline in renal function with age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19212414" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17568781" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28852494" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Age-dependent reference intervals for estimated and measured glomerular filtration rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30403810" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Comparison of high glomerular filtration rate thresholds for identifying hyperfiltration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32499396" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24304885" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20409950" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Flavanols, the Kuna, cocoa consumption, and nitric oxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9039098" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Aging, acculturation, salt intake, and hypertension in the Kuna of Panama.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10364705" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Age, renal perfusion and function in island-dwelling indigenous Kuna Amerinds of Panama.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35850785" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Age and the Course of GFR in Persons Aged 70 and Above.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21832860" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Senile nephrosclerosis--does it explain the decline in glomerular filtration rate with aging?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1751789" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19808242" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Scaling of measured glomerular filtration rate in kidney donor candidates by anthropometric estimates of body surface area, body water, metabolic rate, or liver size.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23027318" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Two novel equations to estimate kidney function in persons aged 70 years or older.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27764827" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Glomerular Filtration Rate in Healthy Living Potential Kidney Donors: A Meta-Analysis Supporting the Construction of the Full Age Spectrum Equation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19414839" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : A new equation to estimate glomerular filtration rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19177154" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14712434" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Measured and estimated GFR in healthy potential kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18621041" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11473658" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Level of hydration and renal function in healthy humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22762315" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Estimating glomerular filtration rate from serum creatinine and cystatin C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23704300" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : GFR estimating equations: getting closer to the truth?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20417681" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Cathepsins and cystatin C in atherosclerosis and obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21112096" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-βand role played in cell migration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19360013" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Potential contribution of adipose tissue to elevated serum cystatin C in human obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23423253" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21454717" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Estimated GFR associates with cardiovascular risk factors independently of measured GFR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23347458" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21944667" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23111824" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Age and association of kidney measures with mortality and end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28125814" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26184510" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32622831" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34459844" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Accounting for Age in the Definition of Chronic Kidney Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16408120" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Renal ENaC subunit, Na-K-2Cl and Na-Cl cotransporter abundances in aged, water-restricted F344 x Brown Norway rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8866401" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Aging and the kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3913500" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : The aging kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18614996" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : The aging kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20872370" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Functional changes in the aging kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18367658" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Aquaporin-2 downregulation in kidney medulla of aging rats is posttranscriptional and is abolished by water deprivation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23602191" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Thiazide-associated hyponatremia: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2220773" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Hyperkalemia in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24424348" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558563" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18400813" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Do we need another equation to estimate GFR from serum creatinine in renal allograft recipients?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22584028" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Demystifying ethnic/sex differences in kidney function: is the difference in (estimating) glomerular filtration rate or in serum creatinine concentration?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27165829" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25403744" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m(2).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1244564" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Prediction of creatinine clearance from serum creatinine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21094997" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21289597" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21357908" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20884698" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23194494" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19567439" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15204431" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Renal function in the elderly (&gt;70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21482743" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : A predictive model for progression of chronic kidney disease to kidney failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26757465" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17855638" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Age affects outcomes in chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17198252" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Incidence of end-stage renal disease among live kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19179315" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Long-term consequences of kidney donation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22034505" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Living kidney donors ages 70 and older: recipient and donor outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25039276" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Mortality and cardiovascular disease among older live kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24284516" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Long-term risks for kidney donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15930096" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Living-donor kidney transplantation: a review of the current practices for the live donor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26544982" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30143068" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : The age-calibrated measured glomerular filtration rate improves living kidney donation selection process.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30904061" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Evaluation of living donors: quo vadis for GFR criteria?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17062598" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23830507" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : The prevalence and characteristics of microalbuminuria in the general population: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20634299" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Urine albumin-to-creatinine ratio: what's in a number?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20634296" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Comparison of different measures of urinary protein excretion for prediction of renal events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24084157" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20966119" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
